Rhinology. 2022 Dec 1;60(6):474-478. doi: 10.4193/Rhin22.053.
ABSTRACT
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.
PMID:36436220 | DOI:10.4193/Rhin22.053
Rhinology. 2022 Dec 1;60(6):474-478. doi: 10.4193/Rhin22.053.
ABSTRACT
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP.
PMID:36436220 | DOI:10.4193/Rhin22.053